WHO Suspends Trial Of Drug Touted By Trump Over Safety Fears For COVID-19 Patients The decision follows another troubling study that found a higher risk of death among COVID-19 patients treated with hydroxychloroquine.

Decision follows study that found a higher risk of death among COVID-19 patients treated with hydroxychloroquine. https://t.co/IkI50ZB59A

— HuffPost (@HuffPost) May 26, 2020